PolyNovo Past Earnings Performance

Past criteria checks 2/6

PolyNovo has been growing earnings at an average annual rate of 10.9%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 36.7% per year. PolyNovo's return on equity is 2.3%, and it has net margins of 1.9%.

Key information

10.9%

Earnings growth rate

11.3%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate36.7%
Return on equity2.3%
Net Margin1.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How PolyNovo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CALZ.F Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23832690
30 Sep 2375-2630
30 Jun 2366-5570
31 Mar 2359-6520
31 Dec 2253-7470
30 Sep 2248-4390
30 Jun 2242-1320
31 Mar 22380290
31 Dec 21351260
30 Sep 2132-2270
30 Jun 2129-5270
31 Mar 2127-5260
31 Dec 2025-5250
30 Sep 2024-5230
30 Jun 2022-4210
31 Mar 2020-4190
31 Dec 1918-4170
30 Sep 1916-3150
30 Jun 1914-3120
31 Mar 1912-4110
31 Dec 189-590
30 Sep 188-590
30 Jun 187-680
31 Mar 186-680
31 Dec 175-680
30 Sep 174-680
30 Jun 174-570
31 Mar 174-460
31 Dec 165-350
30 Sep 164-350
30 Jun 163-350
31 Mar 162-340
31 Dec 150-240
30 Sep 150-230
30 Jun 150-130
31 Mar 150-230
31 Dec 140-330
30 Sep 140-330
30 Jun 140-330
31 Mar 140-230
31 Dec 130-220
30 Sep 130-220
30 Jun 130-120

Quality Earnings: CALZ.F has a high level of non-cash earnings.

Growing Profit Margin: CALZ.F became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CALZ.F has become profitable over the past 5 years, growing earnings by 10.9% per year.

Accelerating Growth: CALZ.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CALZ.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: CALZ.F's Return on Equity (2.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.